Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
Key facts
- Who runs it
- Montefiore Medical Center
- Where
- Greenville, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 17 Dec 2021
- Ended
- Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Peer mentor
- Standard of care
- Record updated
- 20 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- currently incarcerated or recently released from a U.S. jail or prison (6 months)
- Chronic HCV with documented detectable viral load
- 18 years old
- Fluent in English or Spanish
- Resident of the Upstate area of South Carolina
Who cannot take part
- Unable to sign informed consent
- Life expectancy of less than 1 year
- Plans to relocate from the Upstate area of South Carolina in the next 6 months
Where in United States
- Prisma Health-UpstateGreenville, United States
About the trial
What the trial wants to find out
The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with Hepatitis C Virus (HCV) who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.
The 2 groups in the trial
- Peer-enhanced interventionTreatment being tested
Those randomized to the peer-enhanced intervention group will be contacted by a peer mentor within 72 hours of enrollment to discuss the early release period, readiness for HCV treatment, and identify ancillary needs. Individuals randomized to this arm will be provided a study cell phone.
Treatment: Peer mentor
- Standard of carePlacebo, for comparison
If randomized to the standard of care intervention, the participant will only receive passive referral to HCV-care.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- HCV-ACCELERATE Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
- Publications
- Record updated
- 20 April 2026